<VariationArchive VariationID="579583" VariationName="NM_000969.5(RPL5):c.169_172del (p.Asn57fs)" VariationType="Deletion" Accession="VCV000579583" Version="37" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-29" DateCreated="2018-10-10" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="557386" VariationID="579583">
      <GeneList>
        <Gene Symbol="DIPK1A" FullName="divergent protein kinase domain 1A" GeneID="388650" HGNC_ID="HGNC:32213" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="92832729" stop="92961462" display_start="92832729" display_stop="92961462" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="93298285" stop="93427078" display_start="93298285" display_stop="93427078" Strand="-" />
          </Location>
          <OMIM>614542</OMIM>
        </Gene>
        <Gene Symbol="RPL5" FullName="ribosomal protein L5" GeneID="6125" HGNC_ID="HGNC:10360" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="92831986" stop="92841924" display_start="92831986" display_stop="92841924" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="93297593" stop="93307480" display_start="93297593" display_stop="93307480" Strand="+" />
          </Location>
          <OMIM>603634</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000969.5(RPL5):c.169_172del (p.Asn57fs)</Name>
      <CanonicalSPDI>NC_000001.11:92833636:ACAAACA:ACA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="92833637" stop="92833640" display_start="92833637" display_stop="92833640" variantLength="4" positionVCF="92833636" referenceAlleleVCF="GACAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="93299194" stop="93299197" display_start="93299194" display_stop="93299197" variantLength="4" positionVCF="93299193" referenceAlleleVCF="GACAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N57fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000969.5" sequenceAccession="NM_000969" sequenceVersion="5" change="c.169_172delAACA" MANESelect="true">
            <Expression>NM_000969.5:c.169_172delAACA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000969.3" sequenceAccession="NM_000969" sequenceVersion="3" change="c.169_172del">
            <Expression>NM_000969.3:c.169_172del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.93299197_93299200del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.93299197_93299200del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.92833640_92833643del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.92833640_92833643del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011779.2" sequenceAccession="NG_011779" sequenceVersion="2" change="g.6655_6658del">
            <Expression>NG_011779.2:g.6655_6658del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033051.1" sequenceAccession="NG_033051" sequenceVersion="1" change="g.132883_132886del">
            <Expression>NG_033051.1:g.132883_132886del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000969.5" sequenceAccession="NM_000969" sequenceVersion="5" change="c.169_172del" MANESelect="true">
            <Expression>NM_000969.5:c.169_172del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000960.2" sequenceAccession="NP_000960" sequenceVersion="2" change="p.Asn57fs">
            <Expression>NP_000960.2:p.Asn57fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_146333.1" sequenceAccession="NR_146333" sequenceVersion="1" change="n.298_301del">
            <Expression>NR_146333.1:n.298_301del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001252273.2" sequenceAccession="NM_001252273" sequenceVersion="2" change="c.475-606_475-603del">
            <Expression>NM_001252273.2:c.475-606_475-603del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1155" sequenceAccession="LRG_1155">
            <Expression>LRG_1155:g.6655_6658del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1155t1" sequenceAccession="LRG_1155t1">
            <Expression>LRG_1155t1:c.169_172del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1155p1" sequenceAccession="LRG_1155p1" change="p.Asn57fs">
            <Expression>LRG_1155p1:p.Asn57fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1558284033" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="Unknown function" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000969.5(RPL5):c.169_172del (p.Asn57fs) AND Diamond-Blackfan anemia" Accession="RCV000702906" Version="20">
        <ClassifiedConditionList TraitSetID="1756">
          <ClassifiedCondition DB="MedGen" ID="C1260899">Diamond-Blackfan anemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-02-21" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000969.5(RPL5):c.169_172del (p.Asn57fs) AND not provided" Accession="RCV001008074" Version="26">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2019-02-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000969.5(RPL5):c.169_172del (p.Asn57fs) AND Diamond-Blackfan anemia 1" Accession="RCV000761557" Version="10">
        <ClassifiedConditionList TraitSetID="7656">
          <ClassifiedCondition DB="MedGen" ID="C2676137">Diamond-Blackfan anemia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-03-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000969.5(RPL5):c.169_172del (p.Asn57fs) AND Diamond-Blackfan anemia 6" Accession="RCV002249419" Version="10">
        <ClassifiedConditionList TraitSetID="1711">
          <ClassifiedCondition DB="MedGen" ID="C2931850">Diamond-Blackfan anemia 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-09-23" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-23" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2018-10-10" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19061985</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19191325</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19773262</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20960466</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23718193</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1756" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1485" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Blackfan Diamond syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anemia congenital erythroid hypoplastic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aregenerative anemia chronic congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Erythrogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Red cell aplasia, pure hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital hypoplastic anemia</ElementValue>
                <XRef ID="HP:0004810" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aase syndrome</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Diamond-Blackfan anemia</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
                <XRef ID="88854002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DBA</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BDS</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6274" />
                <XRef ID="6274" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.</Attribute>
                <XRef ID="NBK7047" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301769</ID>
                <ID Source="BookShelf">NBK7047</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083626</ID>
              </Citation>
              <XRef ID="124" DB="Orphanet" />
              <XRef ID="C1260899" DB="MedGen" />
              <XRef ID="D029503" DB="MeSH" />
              <XRef ID="MONDO:0015253" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004810" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005545" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1711" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4954" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Aase-Smith syndrome II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Diamond-Blackfan anemia 6</ElementValue>
                <XRef ID="MONDO:0012937" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DBA6</ElementValue>
                <XRef Type="MIM" ID="612561" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.</Attribute>
                <XRef ID="NBK7047" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15568" />
                <XRef ID="15568" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301769</ID>
                <ID Source="BookShelf">NBK7047</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083626</ID>
              </Citation>
              <XRef ID="124" DB="Orphanet" />
              <XRef ID="C2931850" DB="MedGen" />
              <XRef ID="MONDO:0012937" DB="MONDO" />
              <XRef Type="MIM" ID="612561" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7656" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="8808" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diamond-Blackfan anemia 1</ElementValue>
                <XRef ID="MONDO:0007110" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DBA1</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.</Attribute>
                <XRef ID="NBK7047" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15039" />
                <XRef ID="15039" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301769</ID>
                <ID Source="BookShelf">NBK7047</ID>
              </Citation>
              <XRef ID="124" DB="Orphanet" />
              <XRef ID="C2676137" DB="MedGen" />
              <XRef ID="MONDO:0007110" DB="MONDO" />
              <XRef Type="MIM" ID="105650" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1603706" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="3524019|MedGen:C1260899" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000831781" DateUpdated="2024-02-14" DateCreated="2018-10-10" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19061985</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19773262</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20960466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23718193</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19061985</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19773262</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 579583). This variant is also known as 166_169del (56_57del). This premature translational stop signal has been observed in individual(s) with Diamond-Blackfan anemia (PMID: 19061985, 19773262, 20960466, 23718193). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn57Glufs*12) in the RPL5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPL5 are known to be pathogenic (PMID: 19061985, 19773262).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPL5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.93299194_93299197del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1260899" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1747587" SubmissionDate="2019-03-21" DateLastUpdated="2019-03-24" DateCreated="2019-03-24">
        <ClinVarSubmissionID localKey="SUB5314901" submittedAssembly="GRCh37" title="SUB5314901" />
        <ClinVarAccession Accession="SCV000889935" DateUpdated="2019-03-24" DateCreated="2019-03-24" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-03-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.N57Qfs*12 variant in the RPL5 gene is a de novo frameshift variant, which is absent in the gnomAD database and has previously been reported as a pathogenic variant in the ClinVar database (Accession: RCV000702906.1). In summary, the p.N57Qfs*12 variant meets the ACMG criteria to be classified as pathogenic based upon inheritance model, absence from controls and previous ClinVar submission.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Indian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina Sequencing Platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>Targeted gene sequencing: Selective capture and sequencing of the protein coding regions of the genome/genes is performed. Mutations identified in the exonic regions are generally actionable compared to variations that occur in non-coding regions. Targeted sequencing represents a cost-effective approach to detect variants present in multiple/large genes in an individual. DNA extracted from blood was used to perform targeted gene capture using a custom capture kit. The libraries were sequenced to mean &gt;80-100X coverage on Illumina sequencing platform. The sequences obtained are aligned to human reference genome using BWA program and analysed using Picard and GATK version 3.6 to identify variants relevant to the clinical indication. We follow the GATK best practices framework for identification of variants in the sample. Gene annotation of the variants is performed using VEP program against the Ensembl release 87 human gene model. Clinically relevant mutations were annotated using published variants in literature and a set of diseases databases - ClinVar, OMIM, GWAS, HGMD and SwissVar. Common variants are filtered based on allele frequency in 1000 Genome Phase 3, ExAC, EVS, dbSNP147 and 1000 Japanese Genome. Non-synonymous variants effect is calculated using multiple algorithms such as PolyPhen-2, SIFT, Mutation Taster2, Mutation Assessor and LRT. Only non-synonymous and splice site variants found in the clinical exome panel consisting of 8332 genes were used for clinical interpretation. Silent variations that do not result in any change in amino acid in the coding region are not reported.</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Diamond Blackfan anemia panel genes</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001882" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0004835" />
              </Trait>
              <Comment>Proband presented with clinical indications of leukopenia and presence of a few microspherocytes. Proband's parents were homozygous wildtype for the given allele, hence the baby has de novo variant c.169_172delAACA (p.N57Qfs*12) in exon-3 of RPL5 gene.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPL5">
              <Name>ribosomal protein L5</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000969.5:exon 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">D-4512</Name>
            <Name>p.N57Qfs*12</Name>
          </OtherNameList>
          <FunctionalConsequence Value="Unknown function" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_000969.5:c.169_172delAACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="105650" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5314901</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2305805" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:53438|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001167812" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.169_172delAACA variant has been reported previously in association with Diamond-Blackfan anemia, including an apparently de novo occurrence (Cmejla et al., 2009; Quarello et al., 2010; Gerrard et al., 2013). The deletion causes a frameshift starting with codon Asparagine 57, changes this amino acid to a Glutamic acid residue and creates a premature Stop codon at position 12 of the new reading frame, denoted p.Asn57GlufsX12. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is not observed in large population cohorts (Lek et al., 2016). In summary, we consider the variant to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPL5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000969.3:c.169_172delAACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4933877" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000001.11:g.92833637_92833640delACAA|OMIM:612561" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002518994" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPL5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.11:g.92833637_92833640delACAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612561" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7356580" SubmissionDate="2023-06-11" DateLastUpdated="2023-06-24" DateCreated="2023-06-24">
        <ClinVarSubmissionID localKey="NM_000969.5:c.169_172del" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003935092" DateUpdated="2023-06-24" DateCreated="2023-06-24" Type="SCV" Version="1" SubmitterName="Eurofins-Biomnis" OrgID="508486" OrganizationCategory="laboratory" OrgAbbreviation="Biomnis" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Accession Criteria ClinVar Biomnis</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/4j4nscnf/accession_criteria_clinvar_biomnis.docx/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPL5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000969.5:c.169_172del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612561" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13514005</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5196202" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a893749|MedGen:C1260899" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002710870" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-09-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19061985</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19191325</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19773262</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20960466</ID>
          </Citation>
          <Comment>The c.169_172delAACA pathogenic mutation, located in coding exon 3 of the RPL5 gene, results from a deletion of 4 nucleotides between nucleotide positions 169 and 172, causing a translational frameshift with a predicted alternate stop codon. This mutation has been reported as a sporadic or de novo occurrence in multiple DBA patients with associated congenital anomalies. One individual, diagnosed at birth, was reported to have partial anomalous pulmonary venous return and to be unresponsive to steroid therapy (Gazda HT, Am. J. Hum. Genet. 2008 Dec; 83(6):769-80). A patient with flat thenar eminence, grouped carpal bones, and short stature, and another with intellectual disability, myelomeningocele, cleft palate, and facial dysmorphism, have been reported (Quarello P, Haematologica 2010 Feb; 95(2):206-13; Boria I, Hum. Mutat. 2010 Dec; 31(12):1269-79). In a cohort of Czech DBA patients, an individual small for gestational age with flat thenar and facial dysmorphism was described (Cmejla R, Hum. Mutat. 2009 Mar; 30(3):321-7). In addition to the clinical data presented in the literature, since premature stop codons are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPL5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000969.3:c.169_172delAACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1260899" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2467223" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-09">
        <ClinVarSubmissionID localKey="102114|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001245631" DateUpdated="2024-07-15" DateCreated="2020-05-09" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPL5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="G" referenceAllele="GACAA" start="93299193" stop="93299197" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2305805" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2467223" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1747587" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001882" MappingRef="HP">
        <MedGen CUI="C0023530" Name="Leukopenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5196202" TraitType="Disease" MappingType="XRef" MappingValue="C1260899" MappingRef="MedGen">
        <MedGen CUI="C1260899" Name="Diamond-Blackfan anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1603706" TraitType="Disease" MappingType="XRef" MappingValue="C1260899" MappingRef="MedGen">
        <MedGen CUI="C1260899" Name="Diamond-Blackfan anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1747587" TraitType="Disease" MappingType="XRef" MappingValue="105650" MappingRef="OMIM">
        <MedGen CUI="C2676137" Name="Diamond-Blackfan anemia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7356580" TraitType="Disease" MappingType="XRef" MappingValue="612561" MappingRef="OMIM">
        <MedGen CUI="C2931850" Name="Diamond-Blackfan anemia 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1747587" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004835" MappingRef="HP">
        <MedGen CUI="C4025285" Name="Microspherocytosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4933877" TraitType="Disease" MappingType="XRef" MappingValue="612561" MappingRef="OMIM">
        <MedGen CUI="C2931850" Name="Diamond-Blackfan anemia 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

